678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations

• Published in: Annals of oncology Vol. 35; pp. S528 - S529
• Main Authors: Lemech, C., Luke, J.J., Falchook, G.S., Mckean, M., Kichenadasse, G., Teng, C., Vandross, A.L., Salkeni, M.A., Atkinson, V.G., Liu, J.J., Kennedy, A.M., Clark, J., Ryan, M., Schmidt-Kittler, O., Steinhubel, D., Wages, D., Komarnitsky, P., Puzanov, I.
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.09.2024